Finalizing display...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
AMG-837 | 395 | None | 35 | Human | Binding | EC50 | = | 13.00 | 7.89 | - | 3 | Partial agonist activity at human GPR40 expressed in CHO cells measured over 20 secs interval by luminometric analysis | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1016/j.bmcl.2015.11.050 | |
AMG-837 | 395 | None | 35 | Human | Binding | Kd | = | 1.90 | 8.72 | - | 3 | Displacement of [3H]-(S)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid from human recombinant full-length GPR40 expressed in human HEK293 cell membrane assessed as dissociation constant measured after 2 hrs by radioligand competitive assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00892 | |
AMG-837 | 395 | None | 35 | Human | Binding | EC50 | = | 11.00 | 7.96 | - | 3 | Agonist activity at human recombinant full-length Prolink-tagged GPR40 fused with EA-tagged beta-arrestin expressed in human HEK293 cells assessed as induction of beta-arrestin recruitment measured after 90 mins by beta-galactosidase based PathHunter assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00892 | |
AMG-837 | 395 | None | 35 | Human | Binding | Ki | = | 2.20 | 8.66 | - | 3 | Displacement of [3H]-TAK-875 from human recombinant full-length GPR40 expressed in human HEK293 cell membrane incubated for 2 hrs by solid scintillation counting method | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00892 | |
AMG-837 | 395 | None | 35 | Human | Binding | EC50 | = | 2.20 | 8.66 | - | 3 | Agonist activity at human GPR40 expressed in HEK293 cells measured after 18 to 20 hrs by beta-gal based luciferase reporter gene assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acsmedchemlett.6b00331 | |
AMG-837 | 395 | None | 35 | Human | Binding | EC50 | = | 23.00 | 7.64 | - | 3 | Agonist activity at FFA1 receptor (unknown origin) | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1016/j.bmc.2016.09.004 | |
AMG-837 | 395 | None | 35 | Human | Binding | Ki | = | 41.69 | 7.38 | - | 3 | Displacement of 3-(2-Fluoro-4-((2'-methyl-4'-(2-(2-((7-nitrobenzo[c][1,2,5]-oxadiazol-4-yl)amino)ethoxy)ethoxy)-[1,1'-biphenyl]-3-yl)-methoxy)phenyl)propanoic acid from N-terminal NLUC-tagged FFA1 receptor (unknown origin) expressed in human Flp-In T-REX-293 cell membrane coexpressing mGluR5 incubated for 1 hr by equilibrium BRET assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00202 | |
AMG-837 | 395 | None | 35 | Human | Binding | EC50 | = | 154.88 | 6.81 | - | 3 | Agonist activity at human C-terminal eYFP-tagged FFA1 receptor expressed in HEK-293 cells assessed as beta-arrestin2 recruitment incubated for 5 mins by BRET assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00202 | |
AMG-837 | 395 | None | 35 | Human | Binding | EC50 | = | 80.00 | 7.10 | - | 3 | Partial agonist activity at human GPR40 expressed in CHO cells measured over 20 secs interval by luminometric analysis in presence of 0.01% human serum albumin | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1016/j.bmcl.2015.11.050 | |
AMG-837 | 395 | None | 35 | Human | Binding | EC50 | = | 8800.00 | 5.06 | - | 3 | Partial agonist activity at human GPR40 expressed in CHO cells measured over 20 secs interval by luminometric analysis in presence of 100% human serum | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1016/j.bmcl.2015.11.050 | |
AMG-837 | 395 | None | 35 | Human | Binding | EC50 | = | 104.00 | 6.98 | - | 3 | Agonist activity at human GPR40 expressed in CHO cells by aequorin assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/ml400501x | |
AMG-837 | 395 | None | 35 | Human | Binding | EC50 | = | 60.00 | 7.22 | - | 3 | Agonist activity at human FFA1 receptor expressed in CHO cell membranes after 4 hrs by aequorin bioluminescence assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/ml300427u | |
AMG-837 | 395 | None | 35 | Mouse | Binding | EC50 | = | 1.50 | 8.82 | - | 3 | Agonist activity at Prolink-tagged mouse GPR40 fused with EA-tagged beta-arrestin expressed in human U2OS cells assessed as induction of beta-arrestin recruitment measured after 90 mins by beta-galactosidase based PathHunter assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00892 | |
AMG-837 | 395 | None | 35 | Rat | Binding | EC50 | = | 3.20 | 8.49 | - | 3 | Agonist activity at Prolink-tagged rat GPR40 fused with EA-tagged beta-arrestin expressed in human U2OS cells assessed as induction of beta-arrestin recruitment measured after 90 mins by beta-galactosidase based PathHunter assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00892 | |
BENZYLOXYPHENYLPROPANOIC ACID | 58844 | None | 46 | Human | Binding | EC50 | = | 549.54 | 6.26 | - | 2 | Agonist activity at human C-terminal eYFP-tagged FFA1 receptor expressed in HEK-293 cells assessed as beta-arrestin2 recruitment incubated for 5 mins by BRET assay | ChEMBL | 256.1 | 6 | 1 | 2 | 3.28 | O=C(O)CCc1ccc(OCc2ccccc2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00202 | |
BENZYLOXYPHENYLPROPANOIC ACID | 58844 | None | 46 | Human | Binding | Ki | = | 13803.84 | 4.86 | - | 2 | Displacement of 3-(2-Fluoro-4-((2'-methyl-4'-(2-(2-((7-nitrobenzo[c][1,2,5]-oxadiazol-4-yl)amino)ethoxy)ethoxy)-[1,1'-biphenyl]-3-yl)-methoxy)phenyl)propanoic acid from N-terminal NLUC-tagged FFA1 receptor (unknown origin) expressed in human Flp-In T-REX-293 cell membrane coexpressing mGluR5 incubated for 1 hr by equilibrium BRET assay | ChEMBL | 256.1 | 6 | 1 | 2 | 3.28 | O=C(O)CCc1ccc(OCc2ccccc2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00202 | |
CHEMBL1170012 | 10602 | None | 37 | Human | Binding | EC50 | = | 48977.88 | 4.31 | - | 2 | Agonist activity at human FFA1 receptor expressed in CHO-K1 cells assessed as increase in dynamic mass redistribution response by DMR assay | ChEMBL | 315.1 | 3 | 1 | 2 | 3.81 | Cc1ccc(S(=O)(=O)Nc2cccc(C(F)(F)F)c2)cc1 | https://dx.doi.org/10.1016/j.bmcl.2020.127650 | |
CHEMBL1688457 | 58849 | None | 0 | Human | Binding | EC50 | = | 75.00 | 7.12 | - | 2 | Agonist activity at GPR40 (unknown origin) | ChEMBL | 332.1 | 7 | 1 | 2 | 4.95 | O=C(O)CCc1ccc(OCc2cccc(-c3ccccc3)c2)cc1 | https://dx.doi.org/10.1016/j.bmc.2019.115263 | |
CHEMBL1688473 | 58866 | None | 0 | Human | Binding | Ki | = | 32.00 | 7.50 | 1 | 3 | Displacement of 3-[4-({2',6'-dimethyl-6-[(4-[3H])phenylmethoxy]biphenyl-3-yl}methoxy)phenyl]propanoic acid from human GPR40 expressed in CHO membranes after 90 mins by liquid scintillation counting in presence of 0.2 % BSA | ChEMBL | 378.2 | 7 | 1 | 2 | 5.71 | Cc1cccc(C)c1-c1cccc(COc2ccc(CCC(=O)O)c(F)c2)c1 | https://dx.doi.org/10.1021/ml1000855 | |
CHEMBL1688473 | 58866 | None | 0 | Human | Binding | Ki | = | 32.00 | 7.50 | 1 | 3 | Displacement of 3-[4-({2',6'-dimethyl-6-[(4-[3H])phenylmethoxy]biphenyl-3-yl}methoxy)phenyl] propanoic acid from human GPR40 receptor expressed in CHO cell membrane after 90 mins by liquid scintillation counting in the presence of 0.2% BSA | ChEMBL | 378.2 | 7 | 1 | 2 | 5.71 | Cc1cccc(C)c1-c1cccc(COc2ccc(CCC(=O)O)c(F)c2)c1 | https://dx.doi.org/10.1021/jm2016123 |
Showing 1 to 20 of 700 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
α-linolenic acid | 363 | None | 48 | Human | Functional | pEC50 | = | - | 5.15 | 1 | 3 | Unclassified | Guide to Pharmacology | 278.2 | 13 | 1 | 1 | 5.66 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O | https://pubmed.ncbi.nlm.nih.gov/12496284 | |
α-linolenic acid | 363 | None | 48 | Human | Functional | pEC50 | = | - | 5.15 | 1 | 3 | Unclassified | Guide to Pharmacology | 278.2 | 13 | 1 | 1 | 5.66 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O | https://pubmed.ncbi.nlm.nih.gov/12565875 | |
α-linolenic acid | 363 | None | 48 | Human | Functional | pEC50 | = | - | 5.15 | 1 | 3 | Unclassified | Guide to Pharmacology | 278.2 | 13 | 1 | 1 | 5.66 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O | https://pubmed.ncbi.nlm.nih.gov/12629551 | |
α-linolenic acid | 363 | None | 48 | Human | Functional | pEC50 | = | 5.52 | 8.26 | 1 | 3 | Agonist activity at human FFA1 receptor expressed in human 1321N1 cells measured for 50 intervals of 0.4 secs by calcium mobilization assay | Drug Central | 278.2 | 13 | 1 | 1 | 5.66 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O | - | |
α-linolenic acid | 363 | None | 48 | Human | Functional | EC50 | = | 11090.00 | 4.96 | 1 | 3 | Agonist activity at recombinant human GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium flux measured for 120 secs by calcium-5 dye based assay | ChEMBL | 278.2 | 13 | 1 | 1 | 5.66 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O | https://dx.doi.org/10.1016/j.ejmech.2018.08.075 | |
α-linolenic acid | 363 | None | 48 | Human | Functional | EC50 | = | 3000.00 | 5.52 | 1 | 3 | Agonist activity at human FFA1 receptor expressed in human 1321N1 cells measured for 50 intervals of 0.4 secs by calcium mobilization assay | ChEMBL | 278.2 | 13 | 1 | 1 | 5.66 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O | https://dx.doi.org/10.1021/acs.jmedchem.5b01962 | |
α-linolenic acid | 363 | None | 48 | Human | Functional | EC50 | = | 3162.28 | 5.50 | 1 | 3 | Agonist activity at human FFA1 receptor expressed in human 1321N1 cells measured for 50 intervals of 0.4 secs by calcium mobilization assay | ChEMBL | 278.2 | 13 | 1 | 1 | 5.66 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O | https://dx.doi.org/10.1021/acs.jmedchem.5b01962 | |
α-linolenic acid | 363 | None | 48 | Human | Functional | EC50 | = | 2884.03 | 5.54 | 1 | 3 | Agonist activity at FFAR1 expressed in HEK 293 cells assessed as beta-arrestin recruitment after 30 mins by BRET assay | ChEMBL | 278.2 | 13 | 1 | 1 | 5.66 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O | https://dx.doi.org/10.1021/jm300215x | |
α-linolenic acid | 363 | None | 48 | Human | Functional | EC50 | = | 5200.00 | 5.28 | 1 | 3 | Agonist activity at human GPR40 expressed in T-REx HEK293 cells assessed as effect on intracellular calcium concentration by FLIPR assay | ChEMBL | 278.2 | 13 | 1 | 1 | 5.66 | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O | https://dx.doi.org/10.1021/jm800970b | |
2-hydroxylauric acid | 66 | None | 35 | Human | Functional | EC50 | = | 6760.83 | 5.17 | 1 | 2 | Agonist activity at N-terminal FLAG-tagged/C-terminal eYFP-fused human FFA1 receptor expressed in HEK293T cells assessed as induction of beta-arrestin-2 recruitment after 15 mins by BRET assay | ChEMBL | 216.2 | 10 | 2 | 2 | 2.96 | CCCCCCCCCCC(O)C(=O)O | https://dx.doi.org/10.1039/C7MD00130D | |
AMG-837 | 395 | None | 35 | Human | Functional | pEC50 | = | - | 8.50 | -8 | 3 | Unclassified | Guide to Pharmacology | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://pubmed.ncbi.nlm.nih.gov/22859723 | |
AMG-837 | 395 | None | 35 | Human | Functional | EC50 | = | 13.00 | 7.89 | -8 | 3 | Agonist activity at FFA1 (unknown origin) | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1016/j.ejmech.2018.09.071 | |
AMG-837 | 395 | None | 35 | Human | Functional | EC50 | = | 13.00 | 7.89 | -8 | 3 | Agonist activity at FFA1 (unknown origin) | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1016/j.ejmech.2022.114883 | |
AMG-837 | 395 | None | 35 | Human | Functional | EC50 | = | 1.30 | 8.89 | -8 | 3 | Agonist activity at human recombinant full length GPR40 overexpressed in human HEK293 cells assessed as increase in inositol phosphate accumulation in presence of terbium cryptate-labeled anti IP1/d2-labelled IP1 measured after 120 mins by HTRF assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00892 | |
AMG-837 | 395 | None | 35 | Human | Functional | EC50 | = | 15.00 | 7.82 | -8 | 3 | Agonist activity at human recombinant full length GPR40 overexpressed in human HEK293 cells assessed as increase in intracellular calcium level measured over 3 mins by calcium 4 dye based FLIPR assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00892 | |
AMG-837 | 395 | None | 35 | Human | Functional | EC50 | = | 13.00 | 7.89 | -8 | 3 | Agonist activity at GPR40 (unknown origin) by calcium flux assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1016/j.bmcl.2016.10.074 | |
AMG-837 | 395 | None | 35 | Human | Functional | EC50 | = | 169.82 | 6.77 | -8 | 3 | Agonist activity at FFA1 receptor (unknown origin) expressed in human 132N1 cells measured for 90 secs by Fura-2 AM dye based calcium mobilization assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/acs.jmedchem.6b00202 | |
AMG-837 | 395 | None | 35 | Human | Functional | EC50 | = | 41.00 | 7.39 | -8 | 3 | Agonist activity at human GPR40 expressed in mouse A9 cells by inositol phosphate accumulation assay | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/ml400501x | |
AMG-837 | 395 | None | 35 | Human | Functional | EC50 | = | 60.00 | 7.22 | -8 | 3 | Agonist activity at GPR40 expressed in CHO cells after 20 seconds by aequorin bioluminescence assay in presence of 0.1 % human serum | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/ml300133f | |
AMG-837 | 395 | None | 35 | Human | Functional | EC50 | = | 100.00 | 7.00 | -8 | 3 | Agonist activity at human FFA1 receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescence spectrophotometry | ChEMBL | 438.1 | 7 | 1 | 2 | 6.53 | CC#C[C@@H](CC(=O)O)c1ccc(OCc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1 | https://dx.doi.org/10.1021/jm2005699 |
Showing 1 to 20 of 2,105 entries